Correlation Between Evergreen Marine and Alar Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Evergreen Marine and Alar Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evergreen Marine and Alar Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evergreen Marine Corp and Alar Pharmaceuticals, you can compare the effects of market volatilities on Evergreen Marine and Alar Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evergreen Marine with a short position of Alar Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evergreen Marine and Alar Pharmaceuticals.

Diversification Opportunities for Evergreen Marine and Alar Pharmaceuticals

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Evergreen and Alar is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Evergreen Marine Corp and Alar Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alar Pharmaceuticals and Evergreen Marine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evergreen Marine Corp are associated (or correlated) with Alar Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alar Pharmaceuticals has no effect on the direction of Evergreen Marine i.e., Evergreen Marine and Alar Pharmaceuticals go up and down completely randomly.

Pair Corralation between Evergreen Marine and Alar Pharmaceuticals

Assuming the 90 days trading horizon Evergreen Marine Corp is expected to under-perform the Alar Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Evergreen Marine Corp is 1.52 times less risky than Alar Pharmaceuticals. The stock trades about -0.01 of its potential returns per unit of risk. The Alar Pharmaceuticals is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  14,100  in Alar Pharmaceuticals on December 24, 2024 and sell it today you would earn a total of  450.00  from holding Alar Pharmaceuticals or generate 3.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Evergreen Marine Corp  vs.  Alar Pharmaceuticals

 Performance 
       Timeline  
Evergreen Marine Corp 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Evergreen Marine Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Evergreen Marine is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Alar Pharmaceuticals 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Alar Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Alar Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Evergreen Marine and Alar Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Evergreen Marine and Alar Pharmaceuticals

The main advantage of trading using opposite Evergreen Marine and Alar Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evergreen Marine position performs unexpectedly, Alar Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alar Pharmaceuticals will offset losses from the drop in Alar Pharmaceuticals' long position.
The idea behind Evergreen Marine Corp and Alar Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.